Clinical Trial Details
Braintumor Website

[Information provided by: ClinicalTrials.gov, which provides patients, family members, and members of the public easy and free access to information on clinical studies for a wide range of diseases and conditions.]

NCT03574610 : Brain Targets in Patients With Bladder Emptying Difficulties
Phase
AgesMin: 18 Years Max: 80 Years
Eligibility
Inclusion Criteria:

Inclusion Criteria for subjects with neurogenic bladder:

- Patients with clinical diagnosis of neurogenic bladder

- History of any neurologic illness or injury (including but not limited to spinal cord
injury, Multiple Sclerosis, Stroke, spina bifida, Parkinson's, major spine surgery)

- 18 years or older

Specifics for MS patients:

Adult female patients with clinically stable MS [Expanded Disability Status Score (EDSS)
=6.5], with bladder symptoms =3 months, will be screened. Patients will be considered to
have VD if they have an increased Postvoid Residual (= 20% Maximum Cystometric Capacity).
Patients who perform self-catheterization will be included in the VD category as well.

Exclusion Criteria:

Exclusion Criteria for subjects with neurogenic bladder:

- Men (for aims 1 and 2 only), anatomical bladder outlet obstruction (anti-incontinence
procedures, urethral strictures, or advanced pelvic organ prolapse). Severe
debilitating MS, history of seizures, pregnancy or planning to become pregnant,
contraindications to MRI, history of augmentation cystoplasty. Patients with active
UTI can be treated and subsequently screened for the trial.

- Positive urine pregnancy test at enrollment (There are no known risks to a subject's
fetus. There is no known teratogenic risk associated with urodynamics or fMRI) -
Cognitively impaired patients
LinksPermanent Link to THIS page: https://virtualtrials.com/nct/display1trial.cfm?nct=NCT03574610      |      Link to official Clinicaltrials.gov listing
Locations



Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2019 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740